AI-generated summary
This review by the authors summarizes their work on photobiomodulation as a way to selectively activate latent TGF-β1, a growth factor involved in development, immunity and healing. The authors report that a redox-mediated mechanism has been proposed over the past two decades, and they describe light treatments as having been viewed with skepticism because of inconsistent clinical outcomes. The abstract does not report new participant data, and the proposed pathway is presented by the authors as a hypothesis rather than a settled finding.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract is a narrative review by the authors' own group and reports no specific clinical sample sizes or quantitative outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.